Rho-kinase inhibitors for use in the treatment of amyotrophic lateral sclerosis

摘要

The invention relates to a new use of a known Rho kinase inhibitor, fasudil or a fasudil derivative selected from hydroy-fasudil or dimethylfasudil, in the treatment of amyotrophic lateral sclerosis (ALS).